This compound is a chiral pyrimidinedione derivative used as a pharmaceutical intermediate. It features a complex structure with multiple aromatic rings and halogen substituents, indicating its role in the synthesis of specialized active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 830346-50-4
Benzoic acid, 2,4-difluoro-, ion(1-)
pharmaceutical intermediate
3,5-Dimethylisoxazole-4-boronic acid pinacol ester
pharmaceutical intermediate
5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid
pharmaceutical intermediate
8-(Phenylmethyl)-8-azabicyclo[3.2.1]octan-3-one hydrochloride
pharmaceutical intermediate
1,1-Dimethylethyl N-[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
pharmaceutical intermediate
Elagolix
pharmaceutical raw material
Elagolix sodium
pharmaceutical raw material
Ethyl 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl)-1-phenylethyl)amino)butanoate
pharmaceutical intermediate
3-[(2R)-2-amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
AEOBYHAZFRJFPZ-QFIPXVFZSA-N
CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)N)C4=C(C(=CC=C4)OC)F